Perceptive Advisors LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:41 pm Unchanged | 2024-11-14 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 6,485,420 11.500% | 0 (Unchanged) | Filing |
| 2024-02-05 4:14 pm Purchase | 2024-02-01 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 6,485,420 11.900% | 2,857,727 (+78.78%) | Filing |
| 2023-10-18 4:11 pm Purchase | 2023-10-16 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 3,627,693 9.900% | 1,139,891 (+45.82%) | Filing |
| 2022-12-21 4:30 pm Purchase | 2022-12-19 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 2,487,802 9.900% | 2,487,802 (New Position) | Filing |